These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 28177572)
41. Clinical features of patients with Guillain-Barré syndrome at seven hospitals on the East Coast of Australia. Blum S; Reddel S; Spies J; McCombe P J Peripher Nerv Syst; 2013 Dec; 18(4):316-20. PubMed ID: 24172315 [TBL] [Abstract][Full Text] [Related]
42. Use of the International Classification of Functioning, Disability and Health to describe patient-reported disability: a comparison of Guillain Barré syndrome with multiple sclerosis in a community cohort. Khan F; Amatya B; Ng L J Rehabil Med; 2010 Sep; 42(8):708-14. PubMed ID: 20809051 [TBL] [Abstract][Full Text] [Related]
43. Subtypes and Prognosis of Guillain-Barré Syndrome in Southwest China. Zhang G; Li Q; Zhang R; Wei X; Wang J; Qin X PLoS One; 2015; 10(7):e0133520. PubMed ID: 26200903 [TBL] [Abstract][Full Text] [Related]
44. Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh. Islam Z; Jacobs BC; van Belkum A; Mohammad QD; Islam MB; Herbrink P; Diorditsa S; Luby SP; Talukder KA; Endtz HP Neurology; 2010 Feb; 74(7):581-7. PubMed ID: 20157160 [TBL] [Abstract][Full Text] [Related]
45. Recurrent Guillain-Barré syndrome. Kuitwaard K; van Koningsveld R; Ruts L; Jacobs BC; van Doorn PA J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):56-9. PubMed ID: 18931012 [TBL] [Abstract][Full Text] [Related]
46. A comprehensive analysis and immunobiology of autoimmune neurological syndromes during the Zika virus outbreak in Cúcuta, Colombia. Anaya JM; Rodríguez Y; Monsalve DM; Vega D; Ojeda E; González-Bravo D; Rodríguez-Jiménez M; Pinto-Díaz CA; Chaparro P; Gunturiz ML; Ansari AA; Gershwin ME; Molano-González N; Ramírez-Santana C; Acosta-Ampudia Y J Autoimmun; 2017 Feb; 77():123-138. PubMed ID: 28062188 [TBL] [Abstract][Full Text] [Related]
48. Increased cerebrospinal fluid protein and motor conduction studies as prognostic markers of outcome and nerve ultrasound changes in Guillain-Barré syndrome. Kerasnoudis A; Pitarokoili K; Behrendt V; Gold R; Yoon MS J Neurol Sci; 2014 May; 340(1-2):37-43. PubMed ID: 24607336 [TBL] [Abstract][Full Text] [Related]
49. Outcome of Guillain-Barré Syndrome in Tertiary Care Centers in Thailand. Kulkantrakorn K; Sukphulloprat P J Clin Neuromuscul Dis; 2017 Dec; 19(2):51-56. PubMed ID: 29189549 [TBL] [Abstract][Full Text] [Related]
50. Prognostic factors and complication rates for double-filtration plasmapheresis in patients with Guillain-Barré syndrome. Lin JH; Tu KH; Chang CH; Chen YC; Tian YC; Yu CC; Hung CC; Fang JT; Yang CW; Chang MY Transfus Apher Sci; 2015 Feb; 52(1):78-83. PubMed ID: 25544386 [TBL] [Abstract][Full Text] [Related]
51. [Clinical features of Guillain-Barré Syndrome in a tertiary-level hospital in Mexico]. Carrera-Pineda R; Gutiérrez-Casillas S; Amaya-Sánchez LE; Tafoya-Arellano G; Aguilar-Castillo S; Martínez-Marino M; Villamil-Osorio LV; Guerrero-Cantera J Rev Med Inst Mex Seguro Soc; 2017; 55(Suppl 4):S419-S424. PubMed ID: 29799712 [TBL] [Abstract][Full Text] [Related]
52. Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome. Garssen MP; Van Koningsveld R; Van Doorn PA J Neurol; 2006 Sep; 253(9):1143-6. PubMed ID: 16998652 [TBL] [Abstract][Full Text] [Related]
53. Guillain-Barré syndrome: incidence and mortality rates in US hospitals. Alshekhlee A; Hussain Z; Sultan B; Katirji B Neurology; 2008 Apr; 70(18):1608-13. PubMed ID: 18443311 [TBL] [Abstract][Full Text] [Related]
54. Patient characteristics and the effects of intravenous immunoglobulin in patients with Guillain-Barre syndrome. Guzey Aras Y; Tanik O; Dogan Güngen B; Kotan D Ideggyogy Sz; 2016 Nov; 69(11-12):389-395. PubMed ID: 29733556 [TBL] [Abstract][Full Text] [Related]